Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Nicholas Cost

Concepts (400)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Kidney Neoplasms
73
2026
414
17.920
 Why?
Wilms Tumor
40
2026
90
12.060
 Why?
Testicular Neoplasms
24
2026
111
8.910
 Why?
Nephrectomy
39
2026
163
7.500
 Why?
Neoplasms, Germ Cell and Embryonal
15
2026
76
5.900
 Why?
Lymph Node Excision
13
2024
173
3.860
 Why?
Carcinoma, Renal Cell
18
2025
230
3.810
 Why?
Rhabdoid Tumor
7
2026
102
2.990
 Why?
Lower Urinary Tract Symptoms
4
2026
62
2.900
 Why?
Neoplasm Staging
31
2026
1474
2.550
 Why?
Lymph Nodes
9
2023
509
2.460
 Why?
Child
107
2026
22738
2.270
 Why?
Urology
8
2024
63
2.270
 Why?
Child, Preschool
76
2026
11866
2.120
 Why?
Urinary Bladder
5
2024
196
2.070
 Why?
Medical Oncology
7
2023
340
1.990
 Why?
Urodynamics
4
2025
44
1.910
 Why?
Orchiectomy
8
2023
72
1.900
 Why?
Laparoscopy
12
2024
481
1.860
 Why?
Adolescent
77
2026
22569
1.820
 Why?
Infant
64
2026
10089
1.790
 Why?
Rhabdomyosarcoma
5
2022
65
1.760
 Why?
Hydronephrosis
6
2019
36
1.740
 Why?
Urinary Tract
3
2025
47
1.720
 Why?
Vincristine
3
2024
144
1.620
 Why?
Lymphatic Metastasis
12
2022
336
1.550
 Why?
Urologic Surgical Procedures
8
2019
118
1.520
 Why?
Urologists
3
2017
17
1.510
 Why?
Male
115
2026
72992
1.450
 Why?
Humans
166
2026
145750
1.450
 Why?
Urologic Neoplasms
4
2017
31
1.440
 Why?
Radiotherapy
2
2025
206
1.400
 Why?
Prognosis
28
2026
4329
1.360
 Why?
Kidney Pelvis
6
2015
22
1.350
 Why?
Robotics
6
2015
90
1.320
 Why?
Pelvic Neoplasms
3
2025
24
1.320
 Why?
Adrenal Gland Neoplasms
3
2022
98
1.320
 Why?
Pediatrics
7
2025
1124
1.230
 Why?
Practice Patterns, Physicians'
6
2024
1372
1.220
 Why?
Urinary Bladder Neoplasms
4
2021
258
1.170
 Why?
Organ Sparing Treatments
4
2023
37
1.140
 Why?
Doxorubicin
2
2021
403
1.060
 Why?
Ureteral Obstruction
5
2015
63
1.060
 Why?
Female
91
2026
79025
1.040
 Why?
Urinary Bladder Diseases
2
2019
18
1.040
 Why?
Kidney
9
2023
1498
1.020
 Why?
Retrospective Studies
49
2026
17322
0.990
 Why?
Tumor Burden
7
2025
325
0.980
 Why?
Neoplasms
8
2026
2913
0.960
 Why?
Young Adult
37
2026
14250
0.930
 Why?
Kidney Diseases, Cystic
3
2021
24
0.880
 Why?
Rhabdomyosarcoma, Embryonal
2
2022
16
0.880
 Why?
Nephrons
9
2023
23
0.860
 Why?
Biopsy
6
2024
1082
0.840
 Why?
Ribonuclease III
3
2021
43
0.820
 Why?
Mixed Tumor, Malignant
1
2023
4
0.810
 Why?
Sarcoma, Clear Cell
3
2025
10
0.810
 Why?
DEAD-box RNA Helicases
3
2021
84
0.800
 Why?
Sertoli-Leydig Cell Tumor
3
2021
8
0.790
 Why?
Surgeons
4
2025
340
0.770
 Why?
Hypospadias
4
2011
31
0.770
 Why?
Seminoma
3
2021
20
0.760
 Why?
Disease-Free Survival
8
2025
770
0.750
 Why?
Age Factors
14
2025
3346
0.740
 Why?
Urologic Surgical Procedures, Male
4
2018
35
0.740
 Why?
Sarcoma
3
2024
207
0.730
 Why?
Leydig Cell Tumor
3
2021
8
0.730
 Why?
Spermatic Cord Torsion
2
2013
7
0.720
 Why?
Surgical Oncology
2
2025
30
0.700
 Why?
Cryptorchidism
2
2019
16
0.690
 Why?
Paraganglioma
1
2022
64
0.690
 Why?
Pulmonary Blastoma
1
2021
8
0.670
 Why?
Tomography, X-Ray Computed
10
2026
2770
0.670
 Why?
Lung Neoplasms
5
2026
2667
0.660
 Why?
Peripheral Nervous System Diseases
1
2022
134
0.660
 Why?
Pheochromocytoma
2
2019
67
0.650
 Why?
Follow-Up Studies
19
2026
5428
0.640
 Why?
Survival Rate
14
2026
2094
0.640
 Why?
Cancer Survivors
2
2026
338
0.630
 Why?
Molecular Targeted Therapy
3
2025
440
0.620
 Why?
Neoplasm Recurrence, Local
7
2024
1150
0.620
 Why?
Neoplasms, Muscle Tissue
1
2019
3
0.610
 Why?
Infant, Newborn
11
2023
6464
0.610
 Why?
Sex Cord-Gonadal Stromal Tumors
2
2017
5
0.600
 Why?
Cystectomy
1
2019
42
0.600
 Why?
Smooth Muscle Myosins
1
2019
7
0.590
 Why?
Muscle Relaxation
1
2019
28
0.590
 Why?
Myosin Light Chains
1
2019
28
0.590
 Why?
Neoplasm Invasiveness
7
2017
508
0.590
 Why?
Treatment Outcome
28
2026
11793
0.580
 Why?
Retroperitoneal Space
2
2024
18
0.570
 Why?
Diagnostic Imaging
3
2022
337
0.560
 Why?
Fertility Preservation
3
2024
55
0.560
 Why?
Antineoplastic Combined Chemotherapy Protocols
6
2026
1969
0.550
 Why?
Catheterization
1
2019
184
0.550
 Why?
Pregnancy Complications, Neoplastic
1
2018
63
0.550
 Why?
Surveys and Questionnaires
4
2024
6084
0.550
 Why?
Health Care Surveys
2
2017
536
0.550
 Why?
von Hippel-Lindau Disease
1
2018
12
0.550
 Why?
Risk Assessment
12
2026
3752
0.540
 Why?
Testicular Diseases
1
2018
6
0.540
 Why?
Antibiotics, Antineoplastic
1
2019
140
0.540
 Why?
Specimen Handling
1
2019
183
0.540
 Why?
Calculi
1
2018
16
0.530
 Why?
Neoadjuvant Therapy
4
2021
467
0.530
 Why?
Tumor Suppressor Protein p53
2
2012
534
0.520
 Why?
Orchiopexy
3
2019
6
0.520
 Why?
Prospective Studies
12
2026
8075
0.520
 Why?
Conservative Treatment
1
2018
45
0.510
 Why?
Kaplan-Meier Estimate
6
2019
971
0.510
 Why?
Cause of Death
3
2026
471
0.510
 Why?
Radiation Exposure
1
2017
63
0.500
 Why?
Kidney Medulla
1
2016
31
0.500
 Why?
Cytodiagnosis
1
2017
31
0.500
 Why?
Frozen Sections
1
2017
24
0.500
 Why?
Critical Pathways
1
2018
109
0.490
 Why?
Angiomyolipoma
1
2016
21
0.490
 Why?
SEER Program
7
2026
230
0.490
 Why?
Muscle Contraction
1
2019
429
0.470
 Why?
Teratoma
2
2017
124
0.470
 Why?
Postoperative Care
1
2018
286
0.470
 Why?
Tuberous Sclerosis
1
2016
56
0.470
 Why?
Granuloma, Plasma Cell
1
2015
12
0.470
 Why?
Survivorship
2
2026
57
0.450
 Why?
Pediatricians
1
2016
121
0.450
 Why?
Survival Analysis
5
2019
1378
0.440
 Why?
Adult
26
2026
40867
0.440
 Why?
Robotic Surgical Procedures
2
2015
185
0.440
 Why?
Glomerular Filtration Rate
4
2018
765
0.440
 Why?
Abdominal Neoplasms
2
2025
47
0.430
 Why?
Neurofibromatosis 1
2
2019
57
0.420
 Why?
Adenoma
1
2016
218
0.420
 Why?
Societies, Medical
5
2025
900
0.410
 Why?
Prostatic Neoplasms
2
2019
981
0.410
 Why?
Polymorphism, Single Nucleotide
2
2012
2181
0.410
 Why?
Hypertension
1
2022
1276
0.400
 Why?
Acute-Phase Proteins
1
2013
66
0.390
 Why?
Germ-Line Mutation
3
2025
177
0.390
 Why?
Lipocalins
1
2013
35
0.390
 Why?
Minimally Invasive Surgical Procedures
4
2025
189
0.390
 Why?
Ultrasonography
5
2019
788
0.380
 Why?
Databases, Factual
5
2019
1491
0.380
 Why?
Ovarian Neoplasms
3
2021
595
0.380
 Why?
Radiation Protection
1
2013
41
0.380
 Why?
Infertility
2
2024
61
0.380
 Why?
United States
16
2026
16122
0.370
 Why?
Patient Education as Topic
1
2018
777
0.370
 Why?
Neoplasms, Radiation-Induced
1
2013
100
0.370
 Why?
Combined Modality Therapy
5
2025
1270
0.360
 Why?
Biopsy, Needle
1
2013
185
0.360
 Why?
Platelet Aggregation Inhibitors
1
2016
499
0.360
 Why?
Glucose Transporter Type 1
1
2012
48
0.350
 Why?
Multimodal Imaging
1
2013
129
0.350
 Why?
Carcinoma, Medullary
2
2025
16
0.350
 Why?
Multivariate Analysis
5
2018
1547
0.340
 Why?
Neoplasm Metastasis
5
2019
688
0.340
 Why?
Primary Prevention
1
2013
222
0.330
 Why?
Codon
1
2011
92
0.330
 Why?
Incidence
7
2019
2933
0.330
 Why?
Positron-Emission Tomography
1
2013
343
0.330
 Why?
Proline
1
2011
82
0.330
 Why?
Clinical Trials as Topic
2
2026
1062
0.320
 Why?
Seasons
1
2013
538
0.320
 Why?
Suburethral Slings
1
2010
10
0.310
 Why?
Vena Cava, Inferior
1
2011
83
0.310
 Why?
Temperature
1
2013
633
0.310
 Why?
Arginine
1
2011
264
0.310
 Why?
Hernia, Ventral
1
2010
24
0.310
 Why?
Sex Factors
3
2024
2110
0.310
 Why?
Proto-Oncogene Proteins
1
2013
625
0.300
 Why?
Urinary Incontinence
1
2010
65
0.300
 Why?
Urinary Bladder, Neurogenic
1
2010
46
0.300
 Why?
Creatinine
2
2026
515
0.300
 Why?
Mouth Mucosa
1
2009
85
0.300
 Why?
Ureter
4
2014
36
0.290
 Why?
Campomelic Dysplasia
1
2009
2
0.290
 Why?
Dysgerminoma
1
2009
6
0.290
 Why?
Urethra
2
2011
56
0.290
 Why?
Angiogenesis Inhibitors
1
2011
239
0.290
 Why?
Skin Transplantation
1
2009
85
0.290
 Why?
Urolithiasis
1
2009
11
0.290
 Why?
Clitoris
1
2009
9
0.290
 Why?
SOX9 Transcription Factor
1
2009
27
0.290
 Why?
Length of Stay
4
2025
1350
0.290
 Why?
Recovery of Function
1
2013
716
0.290
 Why?
Brachytherapy
2
2021
132
0.280
 Why?
Bone Neoplasms
1
2011
265
0.280
 Why?
Venous Thrombosis
1
2011
196
0.280
 Why?
Surgical Flaps
1
2009
142
0.270
 Why?
Attitude of Health Personnel
1
2016
1196
0.270
 Why?
Time Factors
8
2019
7133
0.270
 Why?
Acute Kidney Injury
1
2015
875
0.260
 Why?
Aged
12
2025
26212
0.260
 Why?
Neuroblastoma
2
2025
174
0.250
 Why?
Calcinosis
1
2009
234
0.250
 Why?
Middle Aged
14
2025
36297
0.250
 Why?
Health Promotion
1
2013
775
0.240
 Why?
Nerve Growth Factor
1
2026
36
0.240
 Why?
Risk Factors
8
2018
10916
0.240
 Why?
Ureterocele
2
2016
7
0.230
 Why?
Postoperative Complications
6
2025
2977
0.220
 Why?
Brain-Derived Neurotrophic Factor
1
2026
154
0.220
 Why?
Vesico-Ureteral Reflux
2
2016
38
0.220
 Why?
Biomarkers, Tumor
3
2025
1329
0.220
 Why?
Mitotic Index
2
2015
25
0.220
 Why?
Carcinoma, Papillary
1
2025
82
0.220
 Why?
Kidney Diseases
1
2009
426
0.210
 Why?
Hypertrophy
2
2019
128
0.210
 Why?
Antineoplastic Agents
3
2025
2219
0.210
 Why?
Genetic Predisposition to Disease
5
2025
2399
0.210
 Why?
Perioperative Care
2
2024
231
0.210
 Why?
Protein Kinase Inhibitors
1
2011
981
0.210
 Why?
Chemotherapy, Adjuvant
4
2013
427
0.200
 Why?
Adenosine Triphosphate
1
2026
500
0.200
 Why?
Clinical Competence
2
2025
1247
0.200
 Why?
Gonadal Dysgenesis
1
2023
7
0.200
 Why?
Adrenal Cortex Neoplasms
1
2024
70
0.190
 Why?
Adrenocortical Carcinoma
1
2024
72
0.190
 Why?
Antineoplastic Agents, Phytogenic
1
2024
178
0.190
 Why?
Lymphocytes
1
2025
376
0.190
 Why?
Mast Cells
1
2024
148
0.190
 Why?
Tumor Suppressor Proteins
1
2025
322
0.190
 Why?
Pubic Bone
1
2022
6
0.180
 Why?
Adaptor Proteins, Signal Transducing
1
2025
426
0.180
 Why?
Monocytes
1
2025
539
0.180
 Why?
Urination
1
2022
47
0.180
 Why?
Blood Platelets
1
2025
379
0.170
 Why?
Algorithms
1
2009
1850
0.170
 Why?
Sertoli Cell Tumor
1
2021
2
0.170
 Why?
Sentinel Lymph Node Biopsy
1
2022
117
0.170
 Why?
Biomarkers
3
2026
4302
0.170
 Why?
Retroperitoneal Neoplasms
1
2021
28
0.170
 Why?
Aniridia
1
2020
5
0.170
 Why?
Diagnosis, Differential
3
2019
1512
0.160
 Why?
PAX6 Transcription Factor
1
2020
21
0.160
 Why?
Testosterone
2
2015
416
0.160
 Why?
Interleukin-2
1
2022
440
0.160
 Why?
Neoplastic Syndromes, Hereditary
1
2021
47
0.160
 Why?
Pneumothorax
1
2021
52
0.160
 Why?
Codon, Nonsense
1
2020
45
0.160
 Why?
Positron Emission Tomography Computed Tomography
2
2019
118
0.160
 Why?
Feasibility Studies
3
2026
1115
0.160
 Why?
Eye Proteins
1
2020
92
0.160
 Why?
Reoperation
3
2014
637
0.160
 Why?
Penile Neoplasms
1
2019
7
0.150
 Why?
Priapism
1
2019
10
0.150
 Why?
Syndrome
1
2021
381
0.150
 Why?
Dose-Response Relationship, Drug
1
2024
2028
0.150
 Why?
Chemoradiotherapy, Adjuvant
1
2019
44
0.150
 Why?
Patient Selection
3
2013
739
0.150
 Why?
Myosin-Light-Chain Kinase
1
2019
19
0.150
 Why?
Large-Conductance Calcium-Activated Potassium Channel beta Subunits
1
2019
8
0.150
 Why?
Large-Conductance Calcium-Activated Potassium Channel alpha Subunits
1
2019
10
0.150
 Why?
Neutrophils
1
2025
1125
0.150
 Why?
Proportional Hazards Models
3
2011
1330
0.150
 Why?
Decision Trees
1
2019
78
0.150
 Why?
Computers
1
2019
66
0.150
 Why?
Genotype
2
2016
1857
0.140
 Why?
Puberty, Precocious
1
2019
12
0.140
 Why?
Dermatofibrosarcoma
1
2018
7
0.140
 Why?
Hospitals
1
2023
733
0.140
 Why?
Genetic Testing
2
2019
483
0.140
 Why?
Self-Examination
1
2018
1
0.140
 Why?
Diagnostic Errors
1
2019
178
0.140
 Why?
Proton Therapy
1
2018
15
0.140
 Why?
Chemoradiotherapy
1
2019
239
0.140
 Why?
Animals
6
2025
38100
0.130
 Why?
Radiotherapy, Adjuvant
1
2018
222
0.130
 Why?
Tertiary Care Centers
1
2019
195
0.130
 Why?
Mutation
1
2009
4090
0.130
 Why?
Analysis of Variance
2
2017
1300
0.130
 Why?
Preoperative Period
1
2018
149
0.130
 Why?
Drug Utilization
1
2018
168
0.130
 Why?
Asymptomatic Diseases
1
2018
104
0.130
 Why?
Aged, 80 and over
4
2019
8346
0.130
 Why?
Unnecessary Procedures
1
2017
54
0.130
 Why?
Registries
3
2025
2410
0.130
 Why?
Testis
1
2018
162
0.130
 Why?
Ultrasonography, Doppler
1
2018
126
0.130
 Why?
Pancreatic Neoplasms
1
2025
928
0.130
 Why?
Intraoperative Period
1
2017
69
0.120
 Why?
General Surgery
1
2019
206
0.120
 Why?
Europe
1
2018
421
0.120
 Why?
Logistic Models
3
2018
2139
0.120
 Why?
Mice
3
2024
18357
0.120
 Why?
Mice, Inbred BALB C
1
2019
1261
0.120
 Why?
Health Knowledge, Attitudes, Practice
1
2025
1419
0.120
 Why?
Feminization
1
2015
6
0.120
 Why?
North America
1
2016
303
0.120
 Why?
Fellowships and Scholarships
1
2019
354
0.110
 Why?
Certification
1
2016
119
0.110
 Why?
Translocation, Genetic
2
2018
120
0.110
 Why?
Pregnancy Outcome
1
2018
504
0.110
 Why?
Models, Statistical
1
2019
672
0.110
 Why?
Practice Guidelines as Topic
2
2020
1582
0.110
 Why?
Learning
1
2019
444
0.110
 Why?
Phosphorylation
1
2019
1708
0.110
 Why?
History, 21st Century
1
2015
222
0.110
 Why?
Anaplasia
2
2024
7
0.100
 Why?
Matched-Pair Analysis
1
2014
37
0.100
 Why?
Forecasting
1
2016
390
0.100
 Why?
Adrenergic alpha-1 Receptor Antagonists
1
2014
18
0.100
 Why?
Genitalia, Female
1
2014
42
0.100
 Why?
TRPM Cation Channels
1
2014
73
0.100
 Why?
Ureteral Calculi
1
2014
15
0.100
 Why?
Kidney Function Tests
1
2014
156
0.100
 Why?
Inflammation
1
2025
2883
0.100
 Why?
Statistics, Nonparametric
1
2014
428
0.100
 Why?
Disease Management
1
2017
653
0.100
 Why?
Lipocalin-2
1
2013
80
0.090
 Why?
Delivery of Health Care
1
2020
947
0.090
 Why?
Estrogens
1
2015
367
0.090
 Why?
Blood Vessels
1
2014
167
0.090
 Why?
Magnetic Resonance Imaging
3
2021
3915
0.090
 Why?
Tissue Array Analysis
1
2012
49
0.090
 Why?
Spermatic Cord
1
2012
1
0.090
 Why?
Autophagy
1
2014
291
0.090
 Why?
Monitoring, Physiologic
1
2014
289
0.090
 Why?
Cohort Studies
5
2016
6032
0.090
 Why?
Immunoenzyme Techniques
1
2012
200
0.090
 Why?
Radiation Dosage
1
2013
193
0.090
 Why?
Fetal Diseases
1
2013
194
0.080
 Why?
Surgical Wound Dehiscence
1
2011
22
0.080
 Why?
Skin Neoplasms
1
2018
852
0.080
 Why?
Carcinoma, Transitional Cell
1
2011
68
0.080
 Why?
Cross-Sectional Studies
2
2014
5921
0.080
 Why?
Thrombectomy
1
2011
78
0.080
 Why?
Bevacizumab
1
2011
168
0.080
 Why?
Compliance
1
2010
50
0.080
 Why?
Texas
1
2011
273
0.080
 Why?
Rectum
1
2011
182
0.080
 Why?
Chi-Square Distribution
1
2011
528
0.080
 Why?
Sulfonamides
1
2014
583
0.080
 Why?
Pyrroles
1
2011
220
0.080
 Why?
Referral and Consultation
1
2016
868
0.070
 Why?
Penis
2
2019
33
0.070
 Why?
Muscle, Smooth
1
2010
153
0.070
 Why?
Operative Time
3
2014
181
0.070
 Why?
Polymerase Chain Reaction
1
2012
1043
0.070
 Why?
Drug Administration Schedule
1
2011
782
0.070
 Why?
Internship and Residency
1
2019
1269
0.070
 Why?
Radiography
1
2011
853
0.070
 Why?
MicroRNAs
1
2014
686
0.070
 Why?
Alleles
1
2011
896
0.070
 Why?
Remission, Spontaneous
2
2021
39
0.070
 Why?
Pilot Projects
1
2014
1897
0.070
 Why?
Congenital Abnormalities
1
2008
109
0.060
 Why?
Predictive Value of Tests
1
2013
2123
0.060
 Why?
Indoles
1
2011
507
0.060
 Why?
Case-Control Studies
1
2014
3634
0.060
 Why?
Kidney Failure, Chronic
1
2012
599
0.060
 Why?
Severity of Illness Index
1
2014
2933
0.060
 Why?
Pregnancy
1
2018
7215
0.060
 Why?
Signal Transduction
1
2019
5223
0.060
 Why?
Cystoscopy
2
2016
21
0.060
 Why?
Nephroma, Mesoblastic
1
2025
2
0.060
 Why?
Biopsy, Large-Core Needle
1
2024
15
0.050
 Why?
Antibodies, Monoclonal, Humanized
1
2011
992
0.050
 Why?
Image-Guided Biopsy
1
2024
41
0.050
 Why?
Adrenalectomy
1
2024
68
0.050
 Why?
Nephroureterectomy
1
2023
2
0.050
 Why?
Antibodies, Monoclonal
1
2011
1505
0.050
 Why?
Delphi Technique
1
2025
333
0.050
 Why?
Sexual Development
1
2023
17
0.050
 Why?
Gonads
1
2023
22
0.050
 Why?
Lymphoma
1
2024
241
0.050
 Why?
Pancreatectomy
1
2025
289
0.050
 Why?
Analgesics, Opioid
2
2024
1154
0.040
 Why?
Germany
1
2020
138
0.040
 Why?
Accreditation
1
2019
101
0.040
 Why?
Hyperplasia
1
2019
177
0.040
 Why?
Mohs Surgery
1
2018
29
0.040
 Why?
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors
1
2018
26
0.030
 Why?
Liver Neoplasms
1
2024
777
0.030
 Why?
In Situ Hybridization, Fluorescence
1
2018
328
0.030
 Why?
Mosaicism
1
2017
73
0.030
 Why?
Ureteroscopy
1
2016
15
0.030
 Why?
Monitoring, Intraoperative
1
2016
66
0.030
 Why?
Von Hippel-Lindau Tumor Suppressor Protein
1
2014
19
0.030
 Why?
Caveolin 1
1
2014
20
0.030
 Why?
Education, Medical, Graduate
1
2019
562
0.030
 Why?
Ureterostomy
1
2014
2
0.030
 Why?
Neoplasm Transplantation
1
2014
246
0.030
 Why?
Oncogenes
1
2014
118
0.030
 Why?
Bone Marrow Neoplasms
1
2013
3
0.020
 Why?
Cicatrix
1
2014
69
0.020
 Why?
Organ Size
1
2014
461
0.020
 Why?
Mice, Nude
1
2014
680
0.020
 Why?
RNA Interference
1
2014
475
0.020
 Why?
HEK293 Cells
1
2014
741
0.020
 Why?
Comparative Genomic Hybridization
1
2011
28
0.020
 Why?
Neoplasm Grading
1
2011
311
0.020
 Why?
Area Under Curve
1
2011
332
0.020
 Why?
Sensitivity and Specificity
1
2015
2000
0.020
 Why?
Gene Silencing
1
2011
202
0.020
 Why?
Preoperative Care
1
2012
380
0.020
 Why?
Quality of Life
1
2022
3210
0.020
 Why?
Dihydrolipoamide Dehydrogenase
1
2009
6
0.020
 Why?
Gene Expression Regulation, Neoplastic
1
2014
1450
0.020
 Why?
Cell Line, Tumor
1
2014
3551
0.020
 Why?
Cost's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (400) concept(s)
_
Co-Authors Expand Description
See all (52) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)